Standard
Development of methodology for alternative testing strategies for the assessment of the toxicological profile of nanoparticles used in medical diagnostics. NanoTEST - EC FP7 project. / Dusinska, Maria; Fjellsbo, Lise Maria; Heimstad, Eldbjorg; Harju, Mikael; Bartonova, Alena; Tran, Lang; Juillerat-Jeanneret, Lucienne; Halamoda, Blanka; Marano, Francelyne; Oland, Sonja; Saunders, Margaret; Cartwright, Laura; Carreira, Sara; Thawley, Susan; Whelan, Maurice; Klein, Christoph; Housiadas, Christos; Volkovova, Katarina; Tulinska, Jana; Beno, Milan; Sebekova, Katarina; Knudsen, Lisbeth E.; Mose, Tina; Castell, José V.; Vil, Maya R.; Gombau, Lourdes; Jepson, Mark; Pojana, Giulio; Marcomini, Antonio.
I:
Journal of Physics: Conference Series, Bind 170, 012039, 2009.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Dusinska, M, Fjellsbo, LM, Heimstad, E, Harju, M, Bartonova, A, Tran, L, Juillerat-Jeanneret, L, Halamoda, B, Marano, F, Oland, S, Saunders, M, Cartwright, L, Carreira, S, Thawley, S, Whelan, M, Klein, C, Housiadas, C, Volkovova, K, Tulinska, J, Beno, M, Sebekova, K
, Knudsen, LE, Mose, T, Castell, JV, Vil, MR, Gombau, L, Jepson, M, Pojana, G & Marcomini, A 2009, '
Development of methodology for alternative testing strategies for the assessment of the toxicological profile of nanoparticles used in medical diagnostics. NanoTEST - EC FP7 project',
Journal of Physics: Conference Series, bind 170, 012039.
https://doi.org/10.1088/1742-6596/170/1/012039APA
Dusinska, M., Fjellsbo, L. M., Heimstad, E., Harju, M., Bartonova, A., Tran, L., Juillerat-Jeanneret, L., Halamoda, B., Marano, F., Oland, S., Saunders, M., Cartwright, L., Carreira, S., Thawley, S., Whelan, M., Klein, C., Housiadas, C., Volkovova, K., Tulinska, J., ... Marcomini, A. (2009).
Development of methodology for alternative testing strategies for the assessment of the toxicological profile of nanoparticles used in medical diagnostics. NanoTEST - EC FP7 project.
Journal of Physics: Conference Series,
170, [012039].
https://doi.org/10.1088/1742-6596/170/1/012039Vancouver
Dusinska M, Fjellsbo LM, Heimstad E, Harju M, Bartonova A, Tran L o.a.
Development of methodology for alternative testing strategies for the assessment of the toxicological profile of nanoparticles used in medical diagnostics. NanoTEST - EC FP7 project.
Journal of Physics: Conference Series. 2009;170. 012039.
https://doi.org/10.1088/1742-6596/170/1/012039Author
Dusinska, Maria ; Fjellsbo, Lise Maria ; Heimstad, Eldbjorg ; Harju, Mikael ; Bartonova, Alena ; Tran, Lang ; Juillerat-Jeanneret, Lucienne ; Halamoda, Blanka ; Marano, Francelyne ; Oland, Sonja ; Saunders, Margaret ; Cartwright, Laura ; Carreira, Sara ; Thawley, Susan ; Whelan, Maurice ; Klein, Christoph ; Housiadas, Christos ; Volkovova, Katarina ; Tulinska, Jana ; Beno, Milan ; Sebekova, Katarina ; Knudsen, Lisbeth E. ; Mose, Tina ; Castell, José V. ; Vil, Maya R. ; Gombau, Lourdes ; Jepson, Mark ; Pojana, Giulio ; Marcomini, Antonio. / Development of methodology for alternative testing strategies for the assessment of the toxicological profile of nanoparticles used in medical diagnostics. NanoTEST - EC FP7 project. I: Journal of Physics: Conference Series. 2009 ; Bind 170.
Bibtex
@article{107868ca342b4aa1b082b2acf85491e9,
title = "Development of methodology for alternative testing strategies for the assessment of the toxicological profile of nanoparticles used in medical diagnostics. NanoTEST - EC FP7 project",
abstract = "Nanoparticles (NPs) have unique, potentially beneficial properties, but their possible impact on human health is still not known. The area of nanomedicine brings humans into direct contact with NPs and it is essential for both public confidence and the nanotech companies that appropriate risk assessments are undertaken in relation to health and safety. There is a pressing need to understand how engineered NPs can interact with the human body following exposure. The FP7 project NanoTEST (www.nanotest-fp7.eu) addresses these requirements in relation to the toxicological profile of NPs used in medical diagnostics.",
author = "Maria Dusinska and Fjellsbo, {Lise Maria} and Eldbjorg Heimstad and Mikael Harju and Alena Bartonova and Lang Tran and Lucienne Juillerat-Jeanneret and Blanka Halamoda and Francelyne Marano and Sonja Oland and Margaret Saunders and Laura Cartwright and Sara Carreira and Susan Thawley and Maurice Whelan and Christoph Klein and Christos Housiadas and Katarina Volkovova and Jana Tulinska and Milan Beno and Katarina Sebekova and Knudsen, {Lisbeth E.} and Tina Mose and Castell, {Jos{\'e} V.} and Vil, {Maya R.} and Lourdes Gombau and Mark Jepson and Giulio Pojana and Antonio Marcomini",
year = "2009",
doi = "10.1088/1742-6596/170/1/012039",
language = "English",
volume = "170",
journal = "Journal of Physics: Conference Series",
issn = "1742-6588",
publisher = "Institute of Physics Publishing Ltd",
}
RIS
TY - JOUR
T1 - Development of methodology for alternative testing strategies for the assessment of the toxicological profile of nanoparticles used in medical diagnostics. NanoTEST - EC FP7 project
AU - Dusinska, Maria
AU - Fjellsbo, Lise Maria
AU - Heimstad, Eldbjorg
AU - Harju, Mikael
AU - Bartonova, Alena
AU - Tran, Lang
AU - Juillerat-Jeanneret, Lucienne
AU - Halamoda, Blanka
AU - Marano, Francelyne
AU - Oland, Sonja
AU - Saunders, Margaret
AU - Cartwright, Laura
AU - Carreira, Sara
AU - Thawley, Susan
AU - Whelan, Maurice
AU - Klein, Christoph
AU - Housiadas, Christos
AU - Volkovova, Katarina
AU - Tulinska, Jana
AU - Beno, Milan
AU - Sebekova, Katarina
AU - Knudsen, Lisbeth E.
AU - Mose, Tina
AU - Castell, José V.
AU - Vil, Maya R.
AU - Gombau, Lourdes
AU - Jepson, Mark
AU - Pojana, Giulio
AU - Marcomini, Antonio
PY - 2009
Y1 - 2009
N2 - Nanoparticles (NPs) have unique, potentially beneficial properties, but their possible impact on human health is still not known. The area of nanomedicine brings humans into direct contact with NPs and it is essential for both public confidence and the nanotech companies that appropriate risk assessments are undertaken in relation to health and safety. There is a pressing need to understand how engineered NPs can interact with the human body following exposure. The FP7 project NanoTEST (www.nanotest-fp7.eu) addresses these requirements in relation to the toxicological profile of NPs used in medical diagnostics.
AB - Nanoparticles (NPs) have unique, potentially beneficial properties, but their possible impact on human health is still not known. The area of nanomedicine brings humans into direct contact with NPs and it is essential for both public confidence and the nanotech companies that appropriate risk assessments are undertaken in relation to health and safety. There is a pressing need to understand how engineered NPs can interact with the human body following exposure. The FP7 project NanoTEST (www.nanotest-fp7.eu) addresses these requirements in relation to the toxicological profile of NPs used in medical diagnostics.
UR - http://www.scopus.com/inward/record.url?scp=67650976769&partnerID=8YFLogxK
U2 - 10.1088/1742-6596/170/1/012039
DO - 10.1088/1742-6596/170/1/012039
M3 - Journal article
AN - SCOPUS:67650976769
VL - 170
JO - Journal of Physics: Conference Series
JF - Journal of Physics: Conference Series
SN - 1742-6588
M1 - 012039
ER -
